This field guide—a collaboration between the World Health Organization (WHO) and AMP—is designed to help health workers at all levels in planning and carrying out field investigations into yellow fever adverse events following...
This field guide, developed by the WHO Epidemic Readiness and Intervention team with input from AMP, is intended for African health professionals working at the central and peripheral levels (physicians, health workers, and decision makers) on...
From June 19-20, 2000, WHO brought together trial investigators, vaccine manufacturers, and other interested parties to discuss whether there was a basis for collaboration on the development of standard methodologies for economic evaluation...
Before the introduction of Haemophilus influenzae type b (Hib) conjugate vaccine in the late 1980s, Hib was the leading cause of bacterial meningitis and one of the leading causes of bacterial pneumonia and sepsis among young children...
AMP convened nearly 100 African and international influenza experts in Marrakech, Morocco from June 1-2, 2010 for “AfriFlu,” a conference on influenza disease burden in Africa. The objective was to share information on influenza...
This WHO report presents an overview of a meeting held from February 9-12, 1999 on the current situation in relation to Haemophilus influenzae type b (Hib) and pneumococcal vaccines. The purpose was to set rational priorities for...
This AMP practical guide aims to promote the use of training development techniques to enhance the skills of health workers in developing countries. In particular, it explains how to develop, implement, and evaluate contextually appropriate...